↓ Read PDF
01 · ABSTRACT

Abstract

Introduction: In patients with heart failure, global longitudinal strain (GLS) early detects decreased ventricular contractility, with prognostic value, but there is no evidence that GLS properly differentiates etiologies in patients with left ventricular ejection fraction <50%.

Methods and aims: 147 patients with heart failure and left ventricular ejection fraction <50% were included retrospectively. The aims were to compare the GLS in patients with heart failure with reduced (<40%) to those with mildly reduced ejection fraction (40-49%) and, to compare GLS between the different etiologies in each of these two subpopulations.

 Results: 78 patients presented mildly reduced (53%) and 69 reduced ejection fraction (47%). The mean GLS was -13.4% ± 3.3% (mildly reduced -14.9% ± 2.9%, reduced -11.7% ± 3.0%, p <0.001). In mildly reduced ejection fraction, the etiologies were ischemic (47.4%), idiopathic (25.6%), tachycardiomyopathy (12.8%), valvular (11.6%), and toxic (2.6%), with similar mean GLS (p = ns among all etiologies). In reduced ejection fraction, the etiology of 50.7% patients was ischemic, 24.6% idiopathic, 10.1% valvular, 8.7% tachycardiomyopathy, and 5.8% toxic, with similar mean GLS (p = ns among all etiologies).

Conclusions: There were no significant differences in GLS between the etiologies of heart failure in any subpopulation. The reduced ejection fraction patients presented worse GLS.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 10 No 9 (2022): Vol.10 Issue 9 September 2022
SectionResearch Articles
Published20 September 2022
DOI10.18103/mra.v10i9.3035
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

MS

Mario Sutil-Vega, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

MR

Marcelo Rizzo, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

FT

Fadwa Taibi-Hajjami, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

CR

Carlos Roca-Guerrero, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

ÍC

Íngrid Colomer Asenjo, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

ML

Meritxell Lloreda Surribas, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

NM

Núria Mallofré Vila, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

GT

Gabriel Torres Ruiz, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

PR

Paola Rojas Flores, MD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

AM

Antoni Martínez-Rubio, PhD

Cardiology Department of the University Hospital of Sabadell (Autonomous University of Barcelona). Parc Taulí 1, 08208 Sabadell, Spain.

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗